(Q55461295)

12 July 2018

title

Immunohistochemical evaluation of O6 -methylguanine DNA methyltransferase (MGMT) expression in 117 cases of glioblastoma. (English)

1 reference

12 July 2018

1 reference

Masaya Miyazaki

1

1 reference

12 July 2018

Hiroshi Nishihara

2

1 reference

12 July 2018

Shunsuke Terasaka

3

1 reference

12 July 2018

Hiroyuki Kobayashi

4

1 reference

12 July 2018

Shigeru Yamaguchi

5

1 reference

12 July 2018

Tamio Ito

6

1 reference

12 July 2018

Yuuta Kamoshima

7

1 reference

12 July 2018

Shin Fujimoto

8

1 reference

12 July 2018

Sadao Kaneko

9

1 reference

12 July 2018

Masahito Katoh

10

1 reference

12 July 2018

Nobuaki Ishii

11

1 reference

12 July 2018

Hiromi Mohri

12

1 reference

12 July 2018

Mishie Tanino

13

1 reference

12 July 2018

Taichi Kimura

14

1 reference

12 July 2018

Shinya Tanaka

15

1 reference

12 July 2018

publication date

7 January 2014

1 reference

12 July 2018

published in

Neuropathology

1 reference

12 July 2018

volume

34

1 reference

12 July 2018

issue

3

1 reference

12 July 2018

page(s)

268-276

1 reference

12 July 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

cites work

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

Glioblastomas: correlation between oligodendroglial components, genetic abnormalities, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

Correlation among pathology, genotype, and patient outcomes in glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

Histological indicators of prognosis in glioblastomas: retinoblastoma protein expression and oligodendroglial differentiation indicate improved survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

Cerebral glioblastoma with oligodendrogliomal component: analysis of 36 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

Prognostic implication of histological oligodendroglial tumor component: clinicopathological analysis of 111 cases of malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

Mechanisms of disease: temozolomide and glioblastoma--look to the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

The role of base excision repair in the sensitivity and resistance to temozolomide-mediated cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

O(6) -methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radio

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

Exclusion of histiocytes/endothelial cells and using endothelial cells as internal reference are crucial for interpretation of MGMT immunohistochemistry in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

The correlation and prognostic significance of MGMT promoter methylation and MGMT protein in glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

O6-Methylguanine-DNA methyltransferase protein expression by immunohistochemistry in brain and non-brain systemic tumours: systematic review and meta-analysis of correlation with methylation-specific polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

Relationship between expression of O6-methylguanine-DNA methyltransferase, glutathione-S-transferase π in glioblastoma and the survival of the patients treated with nimustine hydrochloride: An immunohistochemical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

IDH1 and IDH2 mutations in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

Multivariate analysis of prognostic factors in 106 patients with malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

O(6)-Methylguanine DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression is correlated with progression-free survival in patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

Use of magnetic resonance imaging to assess blood-brain/blood-glioma barrier opening during conformal radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

Bystander killing of breast cancer MCF-7 cells by MDA-MB-231 cells exposed to 5-fluorouracil is mediated via Fas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

Radiation and chemotherapy bystander effects induce early genomic instability events: telomere shortening and bridge formation coupled with mitochondrial dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12091

21 January 2018

Identifiers

DOI

10.1111/NEUP.12091

1 reference

12 July 2018

PubMed ID

24397721

1 reference

12 July 2018